147 related articles for article (PubMed ID: 24844401)
1. Genetic variation across C-reactive protein and risk of prostate cancer.
Markt SC; Rider JR; Penney KL; Schumacher FR; Epstein MM; Fall K; Sesso HD; Stampfer MJ; Mucci LA
Prostate; 2014 Jul; 74(10):1034-42. PubMed ID: 24844401
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in RNASEL associated with prostate cancer risk and progression.
Meyer MS; Penney KL; Stark JR; Schumacher FR; Sesso HD; Loda M; Fiorentino M; Finn S; Flavin RJ; Kurth T; Price AL; Giovannucci EL; Fall K; Stampfer MJ; Ma J; Mucci LA
Carcinogenesis; 2010 Sep; 31(9):1597-603. PubMed ID: 20576793
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality.
Shui IM; Stark JR; Penney KL; Schumacher FR; Epstein MM; Pitt MJ; Stampfer MJ; Tamimi RM; Lindstrom S; Sesso HD; Fall K; Ma J; Kraft P; Giovannucci E; Mucci LA
Prostate; 2012 Feb; 72(2):209-16. PubMed ID: 21563195
[TBL] [Abstract][Full Text] [Related]
4. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II.
Wang MH; Helzlsouer KJ; Smith MW; Hoffman-Bolton JA; Clipp SL; Grinberg V; De Marzo AM; Isaacs WB; Drake CG; Shugart YY; Platz EA
Prostate; 2009 Jun; 69(8):874-85. PubMed ID: 19267370
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk.
Eklund CM; Tammela TL; Schleutker J; Hurme M
Br J Cancer; 2009 Jun; 100(12):1846-51. PubMed ID: 19436291
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies.
Pai JK; Mukamal KJ; Rexrode KM; Rimm EB
PLoS One; 2008 Jan; 3(1):e1395. PubMed ID: 18167554
[TBL] [Abstract][Full Text] [Related]
7. Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrence.
Dluzniewski PJ; Wang MH; Zheng SL; De Marzo AM; Drake CG; Fedor HL; Partin AW; Han M; Fallin MD; Xu J; Isaacs WB; Platz EA
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1774-82. PubMed ID: 22859398
[TBL] [Abstract][Full Text] [Related]
8. Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk.
Nimptsch K; Aleksandrova K; Boeing H; Janke J; Lee YA; Jenab M; Bueno-de-Mesquita HB; Jansen EH; Tsilidis KK; Trichopoulou A; Weiderpass E; Wu C; Overvad K; Tjønneland A; Boutron-Ruault MC; Dossus L; Racine A; Kaaks R; Canzian F; Lagiou P; Trichopoulos D; Palli D; Agnoli C; Tumino R; Vineis P; Panico S; Johansson A; Van Guelpen B; Khaw KT; Wareham N; Peeters PH; Quirós JR; Venceslá García A; Molina-Montes E; Dorronsoro M; Chirlaque MD; Barricarte Gurrea A; Key TJ; Duarte-Salles T; Stepien M; Gunter MJ; Riboli E; Pischon T
Int J Cancer; 2015 Mar; 136(5):1181-92. PubMed ID: 25043606
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein (CRP) gene polymorphisms, CRP levels and risk of incident essential hypertension: findings from an observational cohort of Han Chinese.
Kong H; Qian YS; Tang XF; Zhang J; Gao PJ; Zhang Y; Zhu DL
Hypertens Res; 2012 Oct; 35(10):1019-23. PubMed ID: 22763479
[TBL] [Abstract][Full Text] [Related]
10. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
Schaumberg DA; Christen WG; Kozlowski P; Miller DT; Ridker PM; Zee RY
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2336-40. PubMed ID: 16723442
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival.
Slattery ML; Curtin K; Poole EM; Duggan DJ; Samowitz WS; Peters U; Caan BJ; Potter JD; Ulrich CM
Int J Cancer; 2011 Jun; 128(11):2726-34. PubMed ID: 20949557
[TBL] [Abstract][Full Text] [Related]
13. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
Kathiresan S; Larson MG; Vasan RS; Guo CY; Gona P; Keaney JF; Wilson PW; Newton-Cheh C; Musone SL; Camargo AL; Drake JA; Levy D; O'Donnell CJ; Hirschhorn JN; Benjamin EJ
Circulation; 2006 Mar; 113(11):1415-23. PubMed ID: 16534007
[TBL] [Abstract][Full Text] [Related]
14. Serum High-Sensitive C-Reactive Protein Level and CRP Genetic Polymorphisms Are Associated with Abdominal Aortic Aneurysm.
Shangwei Z; Yingqi W; Jiang X; Zhongyin W; Juan J; Dafang C; Yonghua H; Wei G
Ann Vasc Surg; 2017 Nov; 45():186-192. PubMed ID: 28549956
[TBL] [Abstract][Full Text] [Related]
15. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality.
Stark JR; Li H; Kraft P; Kurth T; Giovannucci EL; Stampfer MJ; Ma J; Mucci LA
Int J Cancer; 2009 Jun; 124(11):2683-9. PubMed ID: 19189403
[TBL] [Abstract][Full Text] [Related]
16. Association of common CRP gene variants with CRP levels and cardiovascular events.
Miller DT; Zee RY; Suk Danik J; Kozlowski P; Chasman DI; Lazarus R; Cook NR; Ridker PM; Kwiatkowski DJ
Ann Hum Genet; 2005 Nov; 69(Pt 6):623-38. PubMed ID: 16266402
[TBL] [Abstract][Full Text] [Related]
17. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
18. Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.
Dhillon PK; Penney KL; Schumacher F; Rider JR; Sesso HD; Pollak M; Fiorentino M; Finn S; Loda M; Rifai N; Mucci LA; Giovannucci E; Stampfer MJ; Ma J
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2618-27. PubMed ID: 21960694
[TBL] [Abstract][Full Text] [Related]
19. Relation of genetic variation in the gene coding for C-reactive protein with its plasma protein concentrations: findings from the Women's Health Initiative Observational Cohort.
Lee CC; You NC; Song Y; Hsu YH; Manson J; Nathan L; Tinker L; Liu S
Clin Chem; 2009 Feb; 55(2):351-60. PubMed ID: 19095725
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
